Search results for "BEC"

showing 10 items of 947 documents

The Competing Influences of Initial Depressive Symptomatology and Early Alliance on Early Outcome: A Preliminary Study

2014

We examined 40 psychotherapies, some delivered in combination with pharma-cotherapy, which were all conducted by cognitive behavioral or psychodynamically oriented therapists in a general hospital center for the treatment of light to moder-ate depressive disorders. Our goal was to examine the relationship between early outcome (defined as change in Beck Depression Inventory scores between sessions 2 and 15) and early therapy alliance (as measured at sessions 1 to 5 by the Working Alliance Inventory). We also wanted to concurrently examine the effect of initial depressive symptomatology (BDI at session 2) on early outcome. For the entire sample, both early alliance and initial depressive sym…

medicine.medical_specialtyOutcome predictorslcsh:BF1-990Beck Depression InventoryCognitionTherapeutic allianceEarly TherapyOutcome (game theory)Alliance factorsDepressive symptomatologyPsychiatry and Mental healthClinical PsychologyAlliancelcsh:PsychologymedicineGeneral hospitalPsychiatryPsychologyDepression (differential diagnoses)Clinical psychologyResearch in Psychotherapy
researchProduct

Somatosensory amplification in hypochondriasis and panic disorder

1999

The aim of this study is to explore the differences and similarities of Somatic Amplification (SA) in both panic and hypochondriasis disorders. An additional objective is to validate the Somatosensory Amplification Scale (SSAS) for use in our cultural context. For these purposes, 34 patients (17 with hypochondriasis and 17 with panic disorder; DSM-III-R criteria) completed the following questionnaires: SSAS, State–Trait Anxiety Inventory, Beck Depression Inventory, MMPI Hypochondriasis Scale, Illness Attitude Scales and Illness Behaviour Questionnaire. The SSAS showed a satisfactory internal consistency (Cronbach's α=0·83), and revealed two components: ‘Internal Stimulus Amplification’ and …

medicine.medical_specialtyPanic disorderSomatosensory amplificationBeck Depression InventoryPanicmedicine.diseasebehavioral disciplines and activitieshumanitiesClinical PsychologyMinnesota Multiphasic Personality InventoryCronbach's alphaInternal consistencymedicineAnxietymedicine.symptomPsychologyPsychiatryClinical psychologyClinical Psychology & Psychotherapy
researchProduct

Non-functioning parathyroid cystic tumour: malignant or not? Report of a case

2017

Parathyroid carcinoma (PC) is a very rare endocrine tumour, usually characterized by symptoms such as a neck mass, dysphonia, severe hypercalcemia exceeding 140 mg/L and elevated serum parathyroid hormone levels, even more than 5 times the upper limit of normal. Non-functioning parathyroid cancer is extremely rare and, in this case, its pre-operative diagnosis is often difficult. A 54-year old female patient, referring dysphagia and dysphonia, underwent neck ultrasound and neck CT. A left thyroid nodule, probably cystic, was found. It presented caudal extent on anterior mediastinum causing compression of the left lateral wall of the trachea. The preoperative calcemia was into the normal ran…

medicine.medical_specialtyParathyroid DiseasesNeck massThyroid LobectomyDiagnosis DifferentialClinical Practiceparathytoid cystic tumor03 medical and health sciences0302 clinical medicinemedicineHumansParathyroid adenomaHyperparathyroidismCystsParathyroid neoplasmbusiness.industryThyroidMiddle Agedmedicine.diseaseParathyroid Neoplasmsmedicine.anatomical_structureParathyroid carcinoma030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologyRadiologymedicine.symptomDifferential diagnosisbusinesshormones hormone substitutes and hormone antagonistsGiornale di Chirurgia - Journal of Surgery
researchProduct

European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

2013

Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recomme…

medicine.medical_specialtyPathologyCIENCIAS MÉDICAS Y DE LA SALUDQuality Assurance Health CareSettore MED/18 - CHIRURGIA GENERALEPopulationMEDLINECiencias de la SaludScientific literatureCOLON CANCERGUIDELINESArticle//purl.org/becyt/ford/3.3 [https]SDG 3 - Good Health and Well-beingHealth caremedicinemedia_common.cataloged_instanceQUALITYHumansMass ScreeningMedical physicsEuropean unioneducationMass screeningEarly Detection of Cancermedia_commoneducation.field_of_studyEvidence-Based Medicinebusiness.industryGastroenterologyÉtica MédicaEvidence-based medicineSCREENINGHealth CareEurope//purl.org/becyt/ford/3 [https]colorectal cancer screening; guidelines; quality assurancebusinessQuality AssuranceColorectal NeoplasmsQuality assurance
researchProduct

Ethanol inhibits astroglial cell proliferation by disruption of phospholipase D-mediated signaling.

2002

The activation of phospholipase D (PLD) is a common response to mitogenic stimuli in various cell types. As PLD-mediated signaling is known to be disrupted in the presence of ethanol, we tested whether PLD is involved in the ethanol-induced inhibition of cell proliferation in rat cortical primary astrocytes. Readdition of fetal calf serum (FCS) to serum-deprived astroglial cultures caused a rapid, threefold increase of PLD activity and a strong mitogenic response; both effects were dependent on tyrosine kinases but not on protein kinase C. Ethanol (0.1-2%) suppressed the FCS-induced, PLD-mediated formation of phosphatidic acid (PA) as well as astroglial cell proliferation in a concentration…

medicine.medical_specialtyPlatelet-derived growth factorIndolestert-Butyl Alcoholmedicine.medical_treatmentButanolsBecaplerminPhosphatidic AcidsNerve Tissue ProteinsBiologyBiochemistryCulture Media Serum-FreeCellular and Molecular Neurosciencechemistry.chemical_compound1-ButanolInternal medicineLysophosphatidic acidmedicinePhospholipase DAnimalsPhosphorylationProtein kinase APlatelet-Derived Growth FactorEndothelin-1EthanolPhospholipase DCell growthGrowth factorPhosphatidic acidDNAProto-Oncogene Proteins c-sisProtein-Tyrosine KinasesGenisteinGrowth InhibitorsCell biologyRatsEndocrinologychemistryFetal Alcohol Spectrum DisordersAstrocyteslipids (amino acids peptides and proteins)Signal transductionVanadatesProtein Processing Post-TranslationalCell DivisionSignal TransductionJournal of neurochemistry
researchProduct

Couple therapy for depression in a naturalistic setting in Finland: a 2-year randomized trial

2012

The dialogical and narrative processes in couple therapy (CT) for depressions project was conducted to develop therapy for depression and to investigate the effectiveness of CT in everyday clinical practice; thus aiming at high external validity. Patients with moderate or major depression were randomized to a CT group (n = 29) and a control group (n = 22). The CT group needed significantly fewer therapy sessions. There were significant differences in favour of the CT group in terms of general mental health (symptom check list), Hamilton depression rating scale, global assessment of functioning and decreasing alcohol use. As regards depressive symptoms using the Beck depression inventory, 79…

medicine.medical_specialtySocial PsychologyGlobal Assessment of FunctioningBeck Depression InventoryMental healthlaw.inventionExternal validityClinical PsychologySymptom check listRandomized controlled trialRating scalelawmedicinePsychiatryPsychologySocial Sciences (miscellaneous)Depression (differential diagnoses)Journal of Family Therapy
researchProduct

The long road for tailored STEMI strategies but a short path for thrombus aspiration

2020

medicine.medical_specialtyThrombus aspirationbusiness.industryCoronary ThrombosisElectrocardiographyPercutaneous Coronary InterventionPath (graph theory)HumansST Elevation Myocardial InfarctionMedicineRadiologyCardiology and Cardiovascular MedicinebusinessThrombectomyInternational Journal of Cardiology
researchProduct

A new thrombectomy catheter device (AngioJet) for the disruption of thrombi: An in vitro study

1999

In this study we examined a new thrombectomy catheter device. Different kinds of in vitro generated thrombi and cadaver thrombi were disrupted in test tubes. The mean disruption rate (and disruption time for 1 g of thrombus) was 225 +/- 65 mg/sec (5 +/- 2 sec) for whole-blood, 117 +/- 60 mg/sec (12 +/- 9 sec) for fibrin, 41 +/- 18 mg/sec (30 +/- 18 sec) for mixed, 70 +/- 42 mg/sec (17 +/- 5 sec) for unorganized, 45 +/- 8 mg/sec (22 +/- 4 sec) for partly, and 5 +/- 1 mg/sec (216 +/- 29 sec) for completely organized cadaver thrombi (P0.05). More than 99% of fragmented particles of whole-blood thrombi were 0-12 microm in diameter. The particle size of fibrin, mixed, and cadaver thrombi was sim…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentIn Vitro TechniquesFibrinCatheterizationCadavermedicineHumansRadiology Nuclear Medicine and imagingParticle SizeThrombusThrombectomybiologybusiness.industryCatheter deviceThrombosisEquipment DesignGeneral MedicineThrombolysismedicine.diseaseThrombosisPulmonary embolismSurgerymedicine.anatomical_structureEmbolismbiology.proteinPulmonary EmbolismCardiology and Cardiovascular MedicineNuclear medicinebusinessArteryCatheterization and Cardiovascular Interventions
researchProduct

Simultaneous cardiocerebral embolization in patients with atrial fibrillation

2020

medicine.medical_specialtyTime Factorsmedicine.medical_treatment[SDV]Life Sciences [q-bio]Myocardial Infarction030204 cardiovascular system & hematologyRisk AssessmentDecision Support Techniques03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineAtrial FibrillationIschaemic strokemedicineHumansThrombolytic TherapyIn patientMyocardial infarctionEmbolizationAngioplasty Balloon CoronaryIschemic StrokeThrombectomybusiness.industryAtrial fibrillationGeneral Medicinemedicine.diseaseCoronary embolismTreatment OutcomeIntracranial EmbolismConcomitantCardiologyStentsCardiology and Cardiovascular MedicinebusinessAlgorithms030217 neurology & neurosurgery
researchProduct

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism

2020

Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those withou…

medicine.medical_specialtyVena Cava FiltersDeep vein01 natural sciencesPostthrombotic Syndromelaw.inventionFibrin Fibrinogen Degradation Products03 medical and health sciencesSex Factors0302 clinical medicineRandomized controlled trialPredictive Value of TestsRisk FactorslawInternal medicineMedical IllustrationFactor V LeidenHumansThrombophiliaMedicineCumulative incidencecardiovascular diseases030212 general & internal medicine0101 mathematicsLife StyleThrombectomyUltrasonographybusiness.industry010102 general mathematicsAge FactorsWarfarinVenous ThromboembolismGeneral Medicinemedicine.diseaseThrombosisPre- and post-test probabilitymedicine.anatomical_structureLower ExtremityPredictive value of testsWarfarinSymptom AssessmentbusinessBiomarkersFactor Xa Inhibitorsmedicine.drugJAMA
researchProduct